This milestone represents significant progress in Ferring’s manufacturing capabilities to meet anticipated growth in demand for Adstiladrin® (nadofaragene firadenovec-vncg), a gene therapy for peo...
The new office is the Firm’s third location in Canada and second in the Pacific Northwest, marking sustained growth in both markets
VANCOUVER, British Columbia -- (BUSINESS WIRE) --
Egon Zehnder,...